Hormone dynamics, pharmacokinetics, safety and efficacy of leuprorelin acetate 6-month depot formulation and tamoxifen adjuvant endocrine therapy combination in premenopausal patients with hormone receptor-positive breast cancer

被引：0
|
作者：
Kurebayashi, J.
Toyama, T.
Sumino, S.
Fujimoto, T.
机构：
[1] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[2] Nagoya City Univ Hosp, Nagoya, Aichi, Japan
[3] Takeda Pharmaceut Co Ltd, Osaka, Japan
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-12-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-12-07
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and acceptability of neoadjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: A network meta-analysis
    Zhang, Tingting
    Feng, Fubin
    Yao, Yan
    Qi, Lingyu
    Tian, Jinhui
    Zhou, Chao
    Dong, Shengjie
    Wang, Xue
    Sun, Changgang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 12393 - 12403
  • [42] A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma
    Mayer, E. L.
    DeMichele, A.
    Rugo, H. S.
    Miller, K.
    Waks, A. G.
    Come, S. E.
    Mulvey, T.
    Jeselsohn, R.
    Overmoyer, B.
    Guo, H.
    Barry, W. T.
    Bartlett, C. Huang
    Koehler, M.
    Winer, E. P.
    Burstein, H. J.
    ANNALS OF ONCOLOGY, 2019, 30 (09) : 1514 - 1520
  • [43] The Cost-Effectiveness of Adjuvant Tamoxifen Treatment of Hormone Receptor-Positive Early Breast Cancer Among Premenopausal and Perimenopausal Ghanaian Women
    Addo, Rebecca
    Haas, Marion
    Goodall, Stephen
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 25 : 196 - 205
  • [44] Efficacy and safety of traditional Chinese medicine in managing bone loss post-endocrine therapy in hormone receptor-positive breast cancer patients
    Chen, Liuxiang
    Zhang, Yuanqi
    Li, Jianwen
    Kalmar, Attila
    MEDICINE, 2024, 103 (41)
  • [45] Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting
    D'Onofrio, Raffaella
    Omarini, Claudia
    Toss, Angela
    Sperduti, Isabella
    Piacentini, Federico
    Barbolini, Monica
    Cortesi, Laura
    Barbieri, Elena
    Pettorelli, Elisa
    Chiavelli, Chiara
    Dominici, Massimo
    Moscetti, Luca
    CLINICAL BREAST CANCER, 2023, 23 (07) : 712 - 720.e3
  • [46] Efficacy and safety of initial five years of adjuvant endocrine therapy in postmenopausal hormone receptor-positive breast cancer: A systematic review and network meta-analysis.
    Liao, Hao
    Zhong, Jianxin
    Pei, Wendi
    Bin, Shao
    Liu, Xiao-Ran
    Rugo, Hope S.
    Li, Huiping
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Use of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer at German Breast Cancer Centers and University Hospitals - Results of an Enquiry (Adjuvant Endocrine Therapy Enquiry)
    Kolben, Thomas
    Engelmann, Susanne
    Maurer, Susanne
    Kolben, Martin
    BREAST CARE, 2012, 7 (01) : 39 - 44
  • [48] Identification of patients with hormone receptor-positive breast cancer who need adjuvant tamoxifen therapy for more than 5 years.
    Wu, Chiao-En
    Chen, Shin-Cheh
    Chang, Hsien-Kun
    Lo, Yung-Feng
    Hsueh, Swei
    Lin, Yung-Chang
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] 3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience
    Caruso, Michele
    Castiglione, Gaetano
    Aiello, Rosanna
    Ali, Marco
    Chiarenza, Maurizio
    Dimarco, Rosanna
    Fallica, Giuseppa
    Di Leo, Maria Grazia
    Sano, Maria Vita
    Taibi, Eleonora
    Zacchia, Alessandra
    Miano, Eleonora
    Caruso, Francesco
    FUTURE ONCOLOGY, 2015, 11 (23) : 3109 - 3112
  • [50] Long-term comparisons of the efficacy, safety, and pregnancy outcomes of adjuvant tamoxifen plus ovarian function suppression in premenopausal Han and Zhuang Chinese patients with hormone receptor-positive early breast cancer
    Tang, Shicong
    Zhang, Qiong
    Tang, Xianghui
    Chen, Dong
    Zhang, Fan
    Liu, Jianlun
    Wei, Wei
    Liu, Dequan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (02) : 641 - 652
12345